Placeholder Banner

Holman: Follow-on Biologics Bill Threatens Innovation By Weakening Patent Rights

June 29, 2009
Chris Holman, Professor at the University of Missouri-Kansas City School of Law and author of Holman's Biotech IP Blog, recently posted a great summary of the patent provisions in the follow-on biologics bill currently under consideration in Congress.

You can read Holman's post here.